Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 339 | 8p23.1 | CTSB | cathepsin B | |
Mouse | - | 339 | 14 D1 | Ctsb | cathepsin B | |
Rat | - | 339 | 15p12 | Ctsb | cathepsin B |
Previous and Unofficial Names ![]() |
cathepsin B1 | CB | RSG-2 |
Database Links ![]() |
|
Specialist databases | |
MEROPS | C01.060 (Hs) |
Other databases | |
Alphafold | P07858 (Hs), P10605 (Mm), P00787 (Rn) |
BRENDA | 3.4.22.1 |
ChEMBL Target | CHEMBL4072 (Hs), CHEMBL5187 (Mm), CHEMBL2602 (Rn) |
Ensembl Gene | ENSG00000164733 (Hs), ENSMUSG00000021939 (Mm), ENSRNOG00000010331 (Rn) |
Entrez Gene | 1508 (Hs), 13030 (Mm), 64529 (Rn) |
Human Protein Atlas | ENSG00000164733 (Hs) |
KEGG Enzyme | 3.4.22.1 |
KEGG Gene | hsa:1508 (Hs), mmu:13030 (Mm), rno:64529 (Rn) |
OMIM | 116810 (Hs) |
Pharos | P07858 (Hs) |
RefSeq Nucleotide | NM_147783 (Hs), NM_147781 (Hs), NM_147782 (Hs), NM_001908 (Hs), NM_147780 (Hs), NM_007798 (Mm), NM_022597 (Rn) |
RefSeq Protein | NP_680093 (Hs), NP_680092 (Hs), NP_680091 (Hs), NP_680090 (Hs), NP_001899 (Hs), NP_031824 (Mm), NP_072119 (Rn) |
UniProtKB | P07858 (Hs), P10605 (Mm), P00787 (Rn) |
Wikipedia | CTSB (Hs) |
Enzyme Reaction ![]() |
||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
Cathepsins B, H and L have become important therapeutic targets as their proteolytic activity has been implicated in several pathological inflammatory conditions, such as arthritis and periodontitis. Therefore, pharmacological inhibitors of these enzymes are in development as novel therapeutics. |
Immuno Process Associations | ||||||||||||
|
1. Elie BT, Gocheva V, Shree T, Dalrymple SA, Holsinger LJ, Joyce JA. (2010) Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie, 92 (11): 1618-24. [PMID:20447439]
2. Mellott DM, Tseng CT, Drelich A, Fajtová P, Chenna BC, Kostomiris DH, Hsu J, Zhu J, Taylor ZW, Kocurek KI et al.. (2021) A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells. ACS Chem Biol, 16 (4): 642-650. [PMID:33787221]
3. Méthot N, Rubin J, Guay D, Beaulieu C, Ethier D, Reddy TJ, Riendeau D, Percival MD. (2007) Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing. J Biol Chem, 282 (29): 20836-46. [PMID:17535802]
4. Porzberg MRB, Groenewold GJM, Lyoo H, Jakob AKMH, Titulaer WHC, Cavina L, Poelaert KCK, Zwaagstra M, Dieteren CEJ, Lemmers JGH et al.. (2025) Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 Mpro and Cathepsin. J Med Chem, [Epub ahead of print]. [PMID:40415551]
5. Tsuda M, Muraoka Y, Nagai M, Aoyagi T, Takeuchi T. (1996) Poststatin, a new inhibitor of prolyl endopeptidase. V. Endopeptidase inhibitory activity of poststatin analogues. J Antibiot, 49 (9): 890-9. [PMID:8931723]
6. Wieczerzak E, Drabik P, Łankiewicz L, Ołdziej S, Grzonka Z, Abrahamson M, Grubb A, Brömme D. (2002) Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. J Med Chem, 45 (19): 4202-11. [PMID:12213061]
C1: Papain: cathepsin B. Last modified on 27/05/2025. Accessed on 02/07/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2343.